Quarterly report pursuant to Section 13 or 15(d)

Fair Value Of Financial Instruments (Details)

v3.21.1
Fair Value Of Financial Instruments (Details) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Carrying Amount [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Cash and cash equivalents $ 199,150 $ 221,118
Restricted cash 40,736 35,986
Notes receivable, net 401,564 409,349
Note payable to BBX Capital, Inc. 75,000 75,000
Lines-of-credit, notes payable, and receivable-backed notes payable 512,358 532,719
Junior subordinated debentures 134,391 138,177
Fair Value [Member]    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Cash and cash equivalents 199,150 221,118
Restricted cash 40,736 35,986
Notes receivable, net 545,870 549,819
Note payable to BBX Capital, Inc. 77,720 78,218
Lines-of-credit, notes payable, and receivable-backed notes payable 518,300 547,400
Junior subordinated debentures $ 120,000 $ 133,500